Snodgrass; H. Ralph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Snodgrass; H. Ralph.The latest application filed is for "therapeutic uses of l-4-chlorokynurenine".

Company Profile

7.19.18

Snodgrass; H. Ralph - South San Francisco CA
Snodgrass; H. Ralph - San Jose CA
Snodgrass; H. Ralph - San Mateo CA
Snodgrass; H. Ralph - Powell OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant 10,980,758 - Snodgrass , et al. April 20, 2	2021-04-20
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant 10,821,089 - Snodgrass , et al. November 3, 2	2020-11-03
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant 10,632,091 - Snodgrass , et al.	2020-04-28
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant 10,617,663 - Snodgrass , et al.	2020-04-14
Therapeutic Uses Of L-4-chlorokynurenine App 20190321317 - SNODGRASS; H. Ralph	2019-10-24
Dosage Forms And Therapeutic Uses Of L-4-chlorokynurenine App 20190133984 - SNODGRASS; H. Ralph ; et al.	2019-05-09
Dosage Forms And Therapeutic Uses Of L-4-chlorokynurenine App 20190125707 - SNODGRASS; H. Ralph ; et al.	2019-05-02
Dosage Forms And Therapeutic Uses Of L-4-chlorokynurenine App 20180369180 - SNODGRASS; H. Ralph ; et al.	2018-12-27
Dosage Forms And Therapeutic Uses Of L-4-chlorokynurenine App 20180289649 - SNODGRASS; H. Ralph ; et al.	2018-10-11
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant 9,993,450 - Snodgrass , et al. June 12, 2	2018-06-12
Dosage forms and therapeutic uses L-4-chlorokynurenine Grant 9,993,453 - Snodgrass , et al. June 12, 2	2018-06-12
Therapeutic Uses Of L-4-chlorokynurenine App 20180140568 - SNODGRASS; H. Ralph ; et al.	2018-05-24
Dosage Forms And Therapeutic Uses L-4-chlorokynurenine App 20160158178 - SNODGRASS; H. Ralph ; et al.	2016-06-09
Dosage Forms And Therapeutic Uses Of L-4-chlorokynurenine App 20150359772 - SNODGRASS; H. Ralph ; et al.	2015-12-17
Toxicity typing using liver stem cells Grant 8,512,957 - Snodgrass August 20, 2	2013-08-20
Toxicity Typing Using Liver Stem Cells App 20120220469 - SNODGRASS; H. Ralph	2012-08-30
Toxicity typing using liver stem cells Grant 8,143,009 - Snodgrass March 27, 2	2012-03-27
Pancreatic Endocrine Progenitor Cells Derived From Pluripotent Stem Cells App 20090280096 - KUBO; Atsushi ; et al.	2009-11-12
Toxicity typing using liver stem cells App 20070111195 - Snodgrass; H. Ralph	2007-05-17
Antibodies binding to polypeptides encoded by developmentally-regulated endothelial cell locus-1 Grant 7,041,801 - Quertermous , et al. May 9, 2	2006-05-09
Methods for treating obesity by inhibiting expression of obese gene product receptor variant App 20050266486 - Snodgrass, H. Ralph ; et al.	2005-12-01
Methods for identifying compounds capable of supplementing the biological activity of leptin Grant 6,953,670 - Snodgrass , et al. October 11, 2	2005-10-11
Methods for using the obese gene and its gene product to identify hematopoietic progenitor cells App 20050158287 - Snodgrass, H. Ralph ; et al.	2005-07-21
Methods for using the obese product to stimulate hematopoietic development Grant 6,838,079 - Snodgrass , et al. January 4, 2	2005-01-04
Detection of a leptin receptor variant and methods for regulating obesity App 20030082612 - Snodgrass, H. Ralph ; et al.	2003-05-01
Methods for using the obese gene and its gene product to stimulate hematopoietic development App 20020197232 - Snodgrass, H. Ralph ; et al.	2002-12-26
Toxicity typing using mesenchymal stem cells App 20020045179 - Snodgrass, H. Ralph	2002-04-18
Methods for using the obese gene and its gene product to stimulate hematopoietic development Grant 6,355,237 - Snodgrass , et al. March 12, 2	2002-03-12
Toxicity typing using liver stem cells App 20020012905 - Snodgrass, H. Ralph	2002-01-31
Toxicity typing using embryoid bodies App 20010039006 - Snodgrass, H. Ralph	2001-11-08
Antibodies specific for Hu-B1.219, a novel hematopoietin receptor Grant 6,005,080 - Snodgrass , et al. December 21, 1	1999-12-21
Detection of a leptin receptor variant and methods for regulating obesity Grant 5,882,860 - Snodgrass , et al. March 16, 1	1999-03-16
Hu-B1.219, a novel human hematopoietin receptor Grant 5,869,610 - Snodgrass , et al. February 9, 1	1999-02-09
Detection of a leptin receptor variant Grant 5,856,098 - Snodgrass , et al. January 5, 1	1999-01-05
Isolated nucleic acid encoding Hu-B1.219, a novel human hematopoietin Grant 5,763,211 - Snodgrass , et al. June 9, 1	1998-06-09
HU-B1.219, a novel human hematopoietin receptor Grant 5,643,748 - Snodgrass , et al. July 1, 1	1997-07-01

Company Registrations

SEC

0001415876

SNODGRASS H. RALPH

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.